Contact
Please use this form to send email to PR contact of this press release:
Kiniksa Announces Positive Data from Phase 2 Trial of Mavrilimumab in Giant Cell Arteritis
TO:
Please use this form to send email to PR contact of this press release:
Kiniksa Announces Positive Data from Phase 2 Trial of Mavrilimumab in Giant Cell Arteritis
TO: